Julie Milder, PhD is currently the Director of Neuroscience for Baszucki Group, a private family foundation, overseeing the metabolic psychiatry research portfolio. Dr. Milder's career spans experience in neuroscience across academia, grantmaking, scientific strategy, and the pharmaceutical industry. Her academic research focused on the effects of a ketogenic diet on mitochondrial function and antioxidant response, exploring its role as a therapy for pediatric-onset epilepsy. It is this foundation that eventually led her to Baszucki Group to work on the emerging field of metabolic psychiatry. In this role, Dr. Milder works with clinicians, researchers, and experts by experience around the globe on projects to generate evidence for the use of metabolic therapies in serious mental illness, integrate research into clinical care for metabolic psychiatry, and speak as an advocate for the science in the community.
We sent a reset password link to the email address you provided.
{{reset.email}}
If you do not see the email, try checking your junk or spam folder.
If you don't receive a link in the email you provided, please click the button below to resend the
verification email.
We sent an verification email to the address you provided. Please check your email to verify your email address.
{{signup.email}}
If you do not see the email, try checking your junk or spam folder.
If you don't receive a link in the email you provided, please click the button below to resend the verification email.